ARIAD PHARMACEUTICALS INC 4

4 · ARIAD PHARMACEUTICALS INC · Filed Sep 28, 2015

Form 4

Period: 2015-09-24

Senior VP, Chief IP Officer

Transactions

Exercise/Conversion
Common Stock
2015-09-24+10,000→ 250,449 total
Sale
Common Stock
2015-09-28$6.46/sh−5,000$32,316→ 240,449 total
Award
Performance stock unit
2015-09-24+20,000→ 20,000 total
→ Common Stock (20,000 underlying)
Exercise/Conversion
Performance stock unit
2015-09-24−10,000→ 10,000 total
→ Common Stock (10,000 underlying)

Footnotes (5)

[F1]Shares were acquired upon vesting of performance stock units awarded on March 19, 2013.
[F2]Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
[F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.22 to $6.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote.
[F4]Each performance stock unit represents a right to receive one share of ARIAD common stock.
[F5]The performance stock units vest as to 50% of the award on 9/24/2015 and 50% of the award on 9/24/2016.

Documents

1 file